We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 87 results
  1. 5,6- and 5,7-Dihydroxytryptamines as Serotoninergic Neurotoxins

    Dihydroxytryptamines are able to selectively destroy central serotonin neurons when catecholaminergic neurons are protected. Compared to serotonin,...
    Justyna Paterak, Roman Stefański in Handbook of Neurotoxicity
    Reference work entry 2022
  2. The Discriminative Stimulus Properties of Drugs Used to Treat Depression and Anxiety

    Drug discrimination is a powerful tool for evaluating the stimulus effects of psychoactive drugs and for linking these effects to pharmacological...
    Adam J. Prus, Joseph H. Porter in The Behavioral Neuroscience of Drug Discrimination
    Chapter 2016
  3. 5,6- and 5,7-Dihydroxytryptamines as Serotoninergic Neurotoxins

    Dihydroxytryptamines are able to selectively destroy central serotonin neurons when catecholaminergic neurons are protected. Compared to serotonin,...
    Justyna Paterak, Roman Stefański in Handbook of Neurotoxicity
    Reference work entry 2014
  4. Species Differences in the Selective Inhibition of Monoamine Oxidase (1-methyl-2-phenylethyl)hydrazine and its Potentiation by Cyanide

    The potentiating effects of cyanide on the inhibition of rat liver mitochondrial monoamine oxidase-A & B and of ox liver mitochondrial MAO-B by...

    Zakia Ben Ramadan, Maria L. Wrang, Keith F. Tipton in Neurochemical Research
    Article 03 April 2007
  5. Scombroid Fish Poisoning

    Scombroid fish poisoning, otherwise known as histamine fish poisoning (HFP), is the most common seafood poisoning in the United States related to the...
    Elijah W. Stommel in Foodborne Diseases
    Chapter 2007
  6. Exogenous gaseous superoxide potentiates the antinociceptive effect of opioid analgesic agents

    The study examined the potentiation of the antinociceptive action of opioid analgesics produced by gaseous superoxide (GS) in the rat hind paw...

    N. Goldstein, T. Lewin, ... O. Konstantinova in Inflammation Research
    Article 01 September 1996
  7. Amine precursor amino acid therapy: From neurochemical basis to clinical aspects

    The particulars regarding the amine precursor therapy for treatment of neuropsychiatric disorders and their neurochemical background are described...

    Teruo Nakajima in Neurochemical Research
    Article 01 February 1996
  8. Drug Interactions and Drug-Metabolising Enzymes

    Induction and inhibition of cytochrome P450 enzymes are mechanisms that underly some of the more serious drug-drug interactions; it is therefore...
    Chapter 1996
  9. Impairment of the Serotoninergic Innervation of the Rat Subcommissural Organ After Early Postnatal X-Irradiation of the Brain Stem

    The rat subcommissural organ (SCO) is remarkable for the glandular activity of its ependymocytes, which release their secretory products in the...
    N. Delhaye-Bouchaud, C. Bouchaud in The Subcommissural Organ
    Conference paper 1993
  10. Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine

    In the first experiment, the conditioned place preference (CPP) paradigm was used to examine the rewarding properties of bilateral microinfusions of...

    S. E. Hemby, G. H. Jones, ... D. B. Neill in Psychopharmacology
    Article 01 March 1992
  11. Iproniazid

    Iproniazid, the first clinically effective MAOI, was studied extensively for its psychiatric effects for a year or two following the favorable report...
    Robert A. Maxwell, Shohreh B. Eckhardt in Drug Discovery
    Chapter 1990
  12. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum

    Amphetamine and other psychostimulant drugs induce perseverative motor behavior in rodents, such as compulsive sniffing, licking and biting. Although...

    Ann E. Kelley, Christopher G. Lang, Andrea M. Gauthier in Psychopharmacology
    Article 01 August 1988
  13. Monamine Oxidase

    The enzyme monoamine oxidase (amine: oxygen oxidoreductase (deaminating) EC 1.4.3.4.) (MAO) catalyses the oxidative deamination of amines according...
    M. B. H. Youdim, J. P. M. Finberg, K. F. Tipton in Catecholamines I
    Chapter 1988
  14. Neurochemical and neuropharmacological properties of 4-Fluorotranylcypromine

    1.

    The 4-fluoro analogue of the monoamine oxidase-inhibiting antidepressant tranylcypromine was compared to the parent drug with regard to the...

    Ronald T. Coutts, Tadimeti S. Rao, ... T. W. Eric Hall in Cellular and Molecular Neurobiology
    Article 01 September 1987
  15. Catecholamine Receptors

    Specific receptors for drugs, hormones, and neurotransmitters are found on the surface membranes of many types of cells. Interaction of a receptor...
    B. B. Wolfe, P. B. Molinoff in Catecholamines I
    Chapter 1988
  16. Marked enhancement by clorgyline of nocturnal and daytime melatonin release in rhesus monkeys

    The type A monoamine oxidase (MAO)-inhibiting antidepressant clorgyline (1 mg/kg/24 days) administered to rhesus monkeys increased night-time...

    D. L. Murphy, N. A. Garrick, ... L. Tamarkin in Psychopharmacology
    Article 01 July 1987
  17. The negative symptoms of schizophrenia and the monoamine oxidase inhibitors

    Thirty chronic ambulatory schizophrenic patients whose main psychopathology was characterized by the persistence of negative symptoms, such as...

    Luigi Bucci in Psychopharmacology
    Article 01 March 1987
  18. Monoamine Oxidase Inhibitors: Animal Pharmacology

    The animal pharmacology of the monoamine oxidase inhibitors (MAOIs*) has been reviewed previously by Zirkle and Kaiser (1964), Biel et al. (1964),...
    Richard F. Squires in Handbook of Psychopharmacology
    Chapter 1987
  19. Monoamine Oxidase, Monoamine-Oxidase-Inhibiting Drugs, and Human Behavior

    Monoamine-oxidase- (MAO)-inhibiting drugs, which reduce the oxidative deamination of the brain biogenic amine neurotransmitters, were the first...
    Dennis L. Murphy in Handbook of Psychopharmacology
    Chapter 1987
  20. Tricyclic and Monoamine Oxidase Inhibitor Antidepressants: Structure-Activity Relationships

    Tricyclic and monoamine oxidase inhibitor (MAOI) antidepressants are the two classes of drugs most frequently used in the treatment of moderate to...
    Robert A. Maxwell, Helen L. White in Handbook of Psychopharmacology
    Chapter 1987
Did you find what you were looking for? Share feedback.